Clay A. Kramer


Clay.Kramer.wg10@wharton.upenn.edu The University of Texas at Austin, Austin, TX B.B.A., High Honors, Finance, 2000


Christine V. Laakmann christine.laakmann.wg10@wharton.upenn.edu


Princeton University, Princeton, NJ B.A., Economics, 2003


Leticia Lazaridis Goldberg, D.M.D. leticia.lazaridis.wg10@wharton.upenn.edu


Universidade Estadual do Rio de Janeiro, Brazil D.M.D., 1999


Universidade Federal do Rio de Janeiro, Brazil Master of Business Science, 2005


To solve societal ills in an entrepreneurial setting.


Zimride, Palo Alto, CA MBA Intern, Summer 2009


Coordinated sales of carpool event software, leading to three major event collaborations. Analyzed busi- ness development strategy, pricing and target customers; utilized findings to create new sales pitch.


Burns McClellan, New York, NY Vice President, Investor Relations, 2004-2008


Oversaw 8 accounts generating annual sales of $850,000. Created and imple- mented investor outreach programs. Advised clients how to manage investor reactions during crises. Recruited, coached and supervised two direct reports as youngest VP in history of firm.


Fabre Kramer Pharmaceuticals, Houston, TX


Associate 2003-2004


Developed out-licensing and investigator meeting presentations, resulting in $30MM partnership with GlaxoSmithKline.


Bear, Stearns & Co. Inc., New York, NY Investment Banking Analyst 2000-2002 Coordinated and created pitch books for client presentations involving repa- triation of foreign assets, off-balance sheet structures, equity derivatives, and equity-linked financings, leading to over $400MM in capital raised.


An opportunity within an entrepreneurial team in the medical device industry.


Medtronic CardioVascular, Santa Rosa, CA Marketing Associate, Endovascular Strategy and Analytics, Summer 2009


Led cross-functional team to develop a needs-based physician segmentation model to support Medtronic’s endovascular stent graft portfolio. Identified and prioritized physician segments based on quantitative primary research and field visits to multiple geographies. Developed algorithm to enable sales force to identify seg- ments and tailor product offerings accordingly.


Othera Pharmaceuticals, Exton, PA Business Development Manager, 2006-2008


Supported CEO and CFO on potential M&A and licensing transactions for ophthalmology and oncology com- pounds. Managed preparation of materials for Series D financing (pri- vate placement memorandum, road show presentations, due diligence, etc.) in conjunction with an invest- ment bank. Developed forecasting models for full R&D pipeline.


Putnam Associates, Burlington, MA Senior Associate Consultant, 2003-2006 Managed case teams of 2-4 associates to develop strategy recommendations for top-tier pharmaceutical clients. Casework includes positioning strate- gies for a Phase 3 product approach- ing FDA approval, share retention strategies for a branded product facing generic entrants, and managed care contracting strategies.


An opportunity to leverage my international business skills and industry experience to develop successful life science ventures.


Earnest Partners, Atlanta, GA Equity Analyst, Summer 2009 Identified investment opportunities for long equity fund through funda- mental analysis of public companies. Additionally, presented stock pitches and evaluated other analysts’ invest- ment theses for a collegiate decision during investment committee meetings.


Lazgold Consulting, Brazil Consultant Partner, 2006-2008


Designed care management programs for corporate clients and managed direct costs in health care, through auditing insurance company payments and authorization process, keeping health care spending growth at 12% below industry benchmark. Led mod- eling and implementation of health care information system, reducing pre-authorization lead-time from 2 weeks to real time.


SulAmerica Seguros, Brazil Senior Consultant, 2005-2006 Performed quantitative analysis and tracked project’s implementation through financial indicators. Restructured corporate strategic planning process: positioning, objec- tives, metrics, targets and Balanced Scorecard maps.


Amil Assistencia Médica Internacional, Brazil


Corporate Analyst, 2003-2005 Conducted competitive analysis, market research and evaluated impact of new health care regulations. Led remodeling of information system for pre-authorization requests and claim approval.


16


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40